Investment Research & Advisory Group »

Ligand Pharmaceuticals In shares owned by Investment Research & Advisory Group

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Investment Research & Advisory Group from 13F filings

Historical chart of Investment Research & Advisory Group investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Investment Research & Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Investment Research & Advisory Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $65k 206 316.09

More positions owned by Investment Research & Advisory Group

Vanguard S&p 500 Etf S&p 500 Etf Shs (VOO)
Apple (AAPL)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Asml Hldg N V Fsponsored Adr 1 Adr Reps 1 Ord N Y Registery Shs (ASML)
Mastercard Inc Class Class A Cl A (MA)
Visa Inc Class A Com Cl A (V)
Charles Schwab Corporation (SCHW)
General Electric (GE)
Meta Platforms Inc Class A Cl A (META)
BlackRock

View all positions for Investment Research & Advisory Group

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
Congress Asset Management
FMR
Nomura Asset Management International
Franklin Resources
Geode Capital Management
Chicago Capital
Stephens Investment Management Group
Dimensional Fund Advisors
Massachusetts Financial Services

View all funds holding Ligand Pharmaceuticals In